Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been
considered promising therapeutic targets for cancer therapy. These cells have self-renewal …

Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset
of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their …

Simple Summary The roles of peroxisome proliferator-activated receptors (PPARs) in
carcinogenesis are increasingly appreciated. With the growing interest in tumor stromal …

Most investigations of iodine metabolism in humans and animals have focused on its role in
thyroid function. However, considerable evidence indicates that iodine could also be …

Increasing studies have reported that cancer stem cells (CSCs) play critical roles in
therapeutic resistance, recurrence, and metastasis of tumors, including cervical cancer …

Cancer stem cells (CSCs) are defined as a subpopulation of malignant tumor cells with
selective capacities for tumor initiation, self‐renewal, metastasis, and unlimited growth into …

Cancer is a widespread worldwide chronic disease. In most cases, the high mortality rate
from cancer correlates with a lack of clear symptoms, which results in late diagnosis for …

Peroxisome proliferator-activated receptors (PPARs) have been extensively studied for over
3 decades and consist of three isotypes, including PPARα, γ, and β/δ, that were originally …

Cervical cancer (CaCx) poses a significant global health challenge, ranking as the fourth
most common cancer among women worldwide. Despite the emergence of advanced …

The high degree of chemical modification of the chitosan chains due to protonated amine
groups allows them to react with many negatively charged surfaces as anionic polymers and …